Evidence map›Paper›PMID 38124749›Full record

ArticleFrontiers in immunology2023

Brewpitopes: a pipeline to refine B-cell epitope predictions during public health emergencies.

Roc Farriol-Duran, Ruben López-Aladid, Eduard Porta-Pardo, Antoni Torres, Laia Fernández-Barat

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Roc Farriol-Duran *Barcelona Supercomputing Center (BSC), Barcelona, Spain.
Ruben López-Aladid *CELLEX Research Laboratories, CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Eduard Porta-PardoBarcelona Supercomputing Center (BSC), Barcelona, Spain.
Antoni TorresCELLEX Research Laboratories, CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Laia Fernández-BaratCELLEX Research Laboratories, CibeRes (Centro de Investigación Biomédica en Red de Enfermedades Respiratorias, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain.
Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ESBarcelona Supercomputing Center · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The application of B-cell epitope identification to develop therapeutic antibodies and vaccine candidates is well established. However, the validation of epitopes is time-consuming and resource-intensive. To alleviate this, in recent years, multiple computational predictors have been developed in the immunoinformatics community. Brewpitopes is a pipeline that curates bioinformatic B-cell epitope predictions obtained by integrating different state-of-the-art tools. We used additional computational predictors to account for subcellular location, glycosylation status, and surface accessibility of the predicted epitopes. The implementation of these sets of rational filters optimizes

Indexed as

Epitopes, B-LymphocyteViral VaccinesEmergenciesEpitopes, T-LymphocyteHumansPublic HealthSARS-CoV-2Epitopes, B-LymphocyteEpitopes, T-LymphocyteViral Vaccinesantibody therapeuticsbioinformatics and computational biologyepitope prediction and antigenicity predictionimmunology and infectious diseasesvaccine development

Identifiers

PMID38124749
PMCPMC10730938
OpenAlexW4389393290

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.